GTC Biotherapeutics (fka GTCB)

[DewDiligence]

New shares and options for executive officers. The shares are
part of the officers’ 2007 bonuses; the options vest over five
years and are exercisable at 0.63 (3/7/08 closing price):

 
 Geoffrey Cox, CEO           73K shares    75K options 
 John Green, CFO             33K shares    25K options 
 Harry Meade, SVP Research   35K shares    25K options 
 Dan Woloshen, Gen. Counsel  30K shares    25K options 
 Greg Liposky, SVP Oprtns    34K shares    25K options 
 Dick Scotland, SVP Regltry  27K shares    25K options